Microbiotica
is an England-based biotechnology company that researches and develops bacterial therapeutics and biomarkers for the treatment of cancer... Read moreMicrobiotica
is an England-based biotechnology company that researches and develops bacterial therapeutics and biomarkers for the treatment of cancer... Read more
News
Feb 26, 2025
Benzinga
Microbiotica: Microbiotica presented new data on the mechanism of action of MB097, a clinical-stage drug candidate being developed as a co-therapy in combination with KEYTRUDA (pembrolizumab) in patients with advanced melanoma
Feb 26, 2025
PharmaTimes
Microbiotica: Microbiotica unveils new data on MB097 at AACR IO meeting
Nov 14, 2024
Cambridge Independent
Microbiotica: Microbiotica's first in-human trial commences
Aug 27, 2024
BioPharma-Reporter
Microbiotica: EU and UK approve Microbiome Medicines for advanced melanoma and ulcerative colitis
Apr 13, 2023
Clinical Trials Arena
Microbiotica: Microbiotica, MSD partner to start melanoma combo therapy trial
Nov 29, 2022
MarketScreener
Microbiotica: IP : Microbiotica Ltd - Microbiotica announces transition of leadership
Nov 29, 2022
FinanzNachrichten
Microbiotica: Microbiotica Announces Transition of Leadership
Nov 29, 2022
MarketScreener
Microbiotica: IP : Microbiotica Ltd - Microbiotica announces transition of leadership
Nov 29, 2022
Business Wire
Microbiotica: Microbiotica Announces Transition of Leadership
Mar 11, 2022
NutraIngredients-USA
Microbiotica: Microbiotica raises 60m to advance microbiome therapeutics for Ulcerative Colitis
